sglt2 inhibitors and glp 1 receptor agonists Combining GLP-1 in Type 2 Diabetes Mellitus: A Scoping Review and Expert Insights for Clinical Practice Utilizing the Nominal Group Technique Illustration of potential synergistic effects
Description
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
This artificial sweetener may negatively impact the gut microbiome, though research is mixed
Olanrewaju OA, Sheeba Fnu, Kumar A, et al
& Porta, C
Therefore, it will be worthwhile and meaningful to explore a GLP-1 sensitizer to enhance the hepatic responsiveness to GLP-1
